U.S. Interactive Media and Services Stock News

What recent performance says about UroGen Pharma (URGN) Without a clear single event driving headlines, UroGen Pharma (URGN) has still drawn attention after a recent share price of US$26.59 and strong moves over the past month and past 3 months. See our latest analysis for UroGen Pharma. Those sharp recent share price returns, including a 47.48% 30 day share price return and 24.54% 90 day share price return, sit on top of a 149.20% 1 year total shareholder return. This indicates that momentum...

Wendy's (WEN) just closed FY 2025 with fourth quarter revenue of US$543 million and basic EPS of US$0.14, alongside net income of US$26 million. Trailing twelve month revenue stood at about US$2.2 billion with EPS of US$0.85. Over recent quarters the company has seen quarterly revenue move from US$523 million in Q1 2025 to US$561 million in Q2 and US$550 million in Q3, with quarterly EPS ranging between US$0.20 and US$0.29 across the first three quarters. This sets up a picture where solid...

NewAmsterdam Pharma (NasdaqGM:NAMS) has wrapped up FY 2025 with fourth quarter revenue of about US$0.03 million and a quarterly loss of US$74.9 million, equal to a basic EPS loss of US$0.62. This puts a spotlight on how much cash is still going into development. The company has seen quarterly revenue range from US$0.03 million to US$19.1 million over the past four quarters, while EPS moved between a loss of US$0.15 and a loss of US$0.93, keeping margins firmly in loss making territory even as...

MP Materials (MP) has closed out FY 2025 with fourth quarter revenue of US$103.7 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$275.5 million and a trailing basic EPS loss of US$0.50. Over recent quarters the company has seen quarterly revenue move from US$60.99 million in Q4 2024 to US$103.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.14 in Q4 2024 to a profit of US$0.05 in Q4 2025. This sets up a results season where investors are...

Why PDD Holdings Stock Is Back on Investors’ Radar PDD Holdings (NasdaqGS:PDD) has drawn attention after a mixed stretch in its share price, with a small move higher over the past week and month, but weaker performance year to date and over the past year. See our latest analysis for PDD Holdings. At a share price of $101.51, PDD Holdings has a slightly positive 7 day share price return of 1.63% and 30 day share price return of 1.98%. However, its year to date share price return shows a 12.30%...

BridgeBio Pharma (BBIO) closed out FY 2025 with Q4 revenue of US$154.2 million and a basic EPS loss of US$0.99, while trailing 12 month revenue stood at US$502.1 million and EPS at a loss of US$3.78. Over the past six quarters, the company has seen quarterly revenue move from US$2.7 million in Q3 2024 to US$154.2 million in Q4 2025, with basic EPS losses ranging between US$0.86 and US$1.40 over that span. This sets a clear backdrop of high revenue levels paired with ongoing losses. For...

In early May 2026, PayPal reported first-quarter revenue of US$8,353 million and net income of US$1,113 million, while unveiling a major reorganization into three business units, a US$1.50 billion multi-year cost-saving plan with large workforce cuts, and continued capital returns via dividends and share repurchases. At the same time, PayPal pushed further into AI-enabled and embedded commerce through new products like PayPal Ads ID and BigCommerce-integrated payments, even as it faced...

Crinetics Pharmaceuticals (CRNX) closed out FY 2025 with Q4 revenue of US$6.2 million and a basic EPS loss of US$1.29, alongside a net loss of US$122.8 million. Trailing 12 month figures show revenue of US$7.7 million and a basic EPS loss of US$4.95 on a net loss of US$465.3 million. The company’s quarterly revenue moved from US$0 in Q3 2024 to US$6.2 million in Q4 2025, while EPS losses widened from US$0.96 to US$1.29 over the same span, which keeps attention on how quickly revenue can scale...

PulteGroup, Inc. recently declared a quarterly dividend of US$0.26 per share, payable on July 2, 2026, to shareholders of record as of the June 16, 2026 ex-dividend and record date. This dividend update comes as homebuilder sentiment weakens amid higher Treasury yields and geopolitical tensions, which are pressuring housing affordability and demand expectations. We’ll now examine how weaker homebuilder confidence amid rising Treasury yields affects PulteGroup’s investment narrative built...

Wondering if D.R. Horton stock is genuinely good value or just riding a housing story that feels familiar? This article breaks down what the current price may really be telling you. The stock last closed at US$145.97, with returns of 6.5% over 30 days and 19.2% over 1 year. This gives you a mix of recent volatility and longer term strength to weigh up. Recent headlines around housing affordability, interest rate expectations, and the health of U.S. homebuilding have kept D.R. Horton in...

Genesis Energy (GEL) has wrapped up FY 2025 with fourth quarter revenue of US$440.8 million and basic EPS of US$0.04, setting a more balanced finish to a year that featured earlier quarterly losses. The company has seen quarterly revenue move from US$398.9 million in Q4 FY 2024 to US$398.3 million in Q1 FY 2025, US$377.3 million in Q2, US$414.0 million in Q3, and finally US$440.8 million in Q4. EPS has ranged from a loss of US$0.60 in Q1 to a modest profit by year end, leaving investors to...

IREN (NasdaqGS:IREN) has reported a mixed Q2 2026, with revenue of US$184.7 million and a net loss of US$155.4 million, which translated to EPS of a US$0.52 loss, setting a very different tone to the strong Q1 print. Over the past six quarters, the company’s revenue has moved from US$52.8 million in Q1 2025 to US$240.3 million in Q1 2026 and then to US$184.7 million in Q2 2026. Over the same period, quarterly EPS has swung from a US$0.27 loss in Q1 2025 to US$1.42 in Q1 2026 and back to a...

Why Disney’s latest earnings matter for shareholders Walt Disney (DIS) has quickly moved back into focus after reporting fiscal second quarter results that topped Wall Street forecasts, supported by stronger streaming profitability and solid contribution from parks, cruises, and other experiences. See our latest analysis for Walt Disney. That upbeat earnings reaction has fed into the share price, which has a 30 day share price return of 13.45% and a 1 year total shareholder return of 4.51%...

Alector (ALEC) FY 2025 earnings snapshot Alector (ALEC) has just closed out FY 2025 with Q4 revenue of about US$6.2 million and a basic EPS loss of roughly US$0.34. On a trailing twelve month basis, revenue stood at around US$21.0 million and EPS at a loss of about US$1.39. Over recent quarters the company has reported quarterly revenue ranging from roughly US$3.3 million to US$7.9 million in 2025, with basic EPS losses between about US$0.30 and US$0.41. This points to a profile where revenue...

Sweetgreen (SG) closed out FY 2025 with fourth quarter revenue of US$155.2 million and a basic EPS loss of US$0.42, with trailing twelve month revenue at US$679.5 million and a TTM basic EPS loss of US$1.14 that keeps the story firmly in loss-making territory. Over recent quarters, revenue has moved between US$166.3 million and US$185.6 million, while quarterly basic EPS losses have ranged from US$0.20 to US$0.42. Taken together, this provides a clear picture of a business still investing...

Site Centers (SITC) has released its FY 2025 numbers with fourth quarter revenue of US$20.2 million and basic EPS of US$2.55, alongside funds from operations of a US$7.2 million loss and FFO per share loss of US$0.14. Over recent periods, revenue has moved from US$61.3 million in Q3 2024 to US$37.3 million in Q4 2024, then to US$42.7 million in Q1 2025 and US$33.4 million and US$26.6 million in Q2 and Q3 2025. Basic EPS has ranged from a US$0.26 loss in Q4 2024 to US$6.31 in Q3 2024, and from...

NuScale Power (SMR) closed out FY 2025 with Q4 revenue of US$1.8 million and a basic EPS loss of US$0.24, alongside a net loss of US$50.8 million, keeping profitability firmly in focus for investors. Over the past year, the company has seen quarterly revenue range from US$0.5 million to US$34.2 million, while basic EPS moved between a loss of US$0.11 and a much larger loss of US$1.85. This underscores how sensitive margins remain to project timing and cost swings. With revenue forecasts...

Tecnoglass (TGLS) has just wrapped up FY 2025 with fourth quarter revenue of US$245.3 million and basic EPS of US$0.57, rounding out a trailing twelve month tally of US$983.6 million in revenue and US$3.42 in basic EPS. Over the past six quarters, revenue has ranged from US$222.3 million to US$260.5 million per quarter while basic EPS has moved between US$0.57 and US$1.05. This gives investors a clear view of how the top and bottom lines have tracked together. With trailing net profit margin...

If you are wondering whether McCormick's current share price reflects its underlying value or if sentiment has moved too far in one direction, this article breaks down what the numbers indicate about valuation. The stock last closed at US$47.90, with returns of a 5.8% decline over 7 days, a 6.1% decline over 30 days, a 28.8% decline year to date, a 35.3% decline over 1 year, a 42.4% decline over 3 years and a 40.9% decline over 5 years. These figures may prompt you to consider whether the...

Sila Realty Trust (SILA) has closed out FY 2025 with fourth quarter revenue of US$50.7 million, basic EPS of US$0.09 and funds from operations of US$29.8 million, giving investors a clean snapshot of both top line activity and REIT specific cash generation. The company has seen quarterly revenue move from US$46.5 million in Q4 2024 to US$50.7 million in Q4 2025, while basic EPS shifted from US$0.20 to US$0.09 over the same stretch. This sets up an earnings season where the focus lands...

If you have been wondering whether Analog Devices at around US$408 per share still offers value, it helps to step back and look at what the recent price action and fundamentals might be saying. The stock shows returns of 1.6% over the last week, 24.8% over the last month, 49.2% year to date and 104.5% over the last year. This can change how investors think about both upside potential and risk. Recent coverage has focused on Analog Devices as one of the larger US semiconductor stocks, with...

PAR Technology (PAR) closed out FY 2025 with fourth quarter revenue of US$120.1 million and a basic EPS loss of US$0.51, while trailing twelve month revenue reached US$455.5 million alongside a basic EPS loss of US$2.09. The company has seen quarterly revenue move from US$105.0 million and a basic EPS loss of US$0.68 in Q4 2024 to US$120.1 million and a basic EPS loss of US$0.51 in Q4 2025, set against trailing revenue of US$349.9 million and a basic EPS loss of US$2.63 a year earlier. This...

Inogen (INGN) just closed out FY 2025 with Q4 revenue of US$81.7 million, a basic EPS loss of US$0.26 and net income loss of US$7.1 million, set against trailing 12 month revenue of US$348.7 million and a basic EPS loss of US$0.86. Over recent quarters the company has seen quarterly revenue move from US$80.1 million in Q4 2024 to US$92.4 million in Q3 2025 before landing at US$81.7 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.15 and US$0.41 across that span. With...

Evommune (EVMN) has just wrapped up FY 2025 with Q4 revenue at US$0 million, a basic EPS loss of US$1.43 per share, and trailing twelve month revenue of US$13 million against a net loss of US$68.87 million. Over recent periods, the company has seen quarterly revenue move between US$0 million and US$10 million while quarterly EPS losses ranged from about US$1.43 to US$14.54 per share. This sets a clear picture of a business still investing heavily ahead of potential payoffs. For investors, the...